These changes were not observed in FLT3-ITD AML (MOLM13 and MV4-11), and the Rb maintains its dephosphorylated state showing that palbociclib is not as effective in cell lines with wild-type FLT3. The gene discussed is FLT3; the disease is acute myeloid leukemia.